MedPath

FRED HUTCHINSON CANCER CENTER

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
https://www.fredhutch.org

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
First Posted Date
2004-05-03
Last Posted Date
2010-04-02
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
280
Registration Number
NCT00003972
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission

Phase 1
Completed
Conditions
Ovarian Cancer
First Posted Date
2004-04-29
Last Posted Date
2010-09-15
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
45
Registration Number
NCT00002977
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Phase 1
Completed
Conditions
Sarcoma
First Posted Date
2004-04-27
Last Posted Date
2010-09-20
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
16
Registration Number
NCT00003081
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Phase 2
Completed
Conditions
Breast Cancer
Chronic Myeloproliferative Disorders
Gestational Trophoblastic Tumor
Kidney Cancer
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer
First Posted Date
2004-04-27
Last Posted Date
2011-11-30
Lead Sponsor
Fred Hutchinson Cancer Center
Registration Number
NCT00003887
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Phase 3
Completed
Conditions
Graft Versus Host Disease
Leukemia
Lymphoma
First Posted Date
2004-04-26
Last Posted Date
2011-11-30
Lead Sponsor
Fred Hutchinson Cancer Center
Registration Number
NCT00002456
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

Phase 2
Completed
Conditions
Leukemia
Lymphoma
First Posted Date
2004-04-26
Last Posted Date
2011-11-30
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
50
Registration Number
NCT00002553
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-04-23
Last Posted Date
2016-10-04
Lead Sponsor
Fred Hutchinson Cancer Center
Registration Number
NCT00003899
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2004-04-23
Last Posted Date
2011-06-23
Lead Sponsor
Fred Hutchinson Cancer Center
Registration Number
NCT00003146
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2004-04-23
Last Posted Date
2010-04-02
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
60
Registration Number
NCT00004013
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Phase 1
Completed
Conditions
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Refractory Multiple Myeloma
Stage III Multiple Myeloma
Interventions
Drug: melphalan
Procedure: autologous hematopoietic stem cell transplantation
Procedure: autologous bone marrow transplantation
Procedure: peripheral blood stem cell transplantation
Radiation: total-body irradiation
Drug: cyclosporine
Drug: mycophenolate mofetil
Biological: therapeutic allogeneic lymphocytes
First Posted Date
2004-04-15
Last Posted Date
2020-02-06
Lead Sponsor
Fred Hutchinson Cancer Center
Target Recruit Count
40
Registration Number
NCT00003954
Locations
🇺🇸

University of Colorado, Denver, Colorado, United States

🇺🇸

City of Hope, Duarte, California, United States

🇺🇸

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath